GSK plc reported the vesting of bonuses and share transactions for executives on February 17-18, 2025, involving 81,703 ordinary shares at £14.195 and 45,690 ADS at $36.61, primarily for tax liability purposes. These transactions include multiple executives exercising nil-cost options and selling shares to meet tax obligations derived from bonus awards granted in 2022.